Comparison of the efficacy and tolerability of elobixibat plus sodium picosulfate with magnesium citrate and split-dose 2-L polyethylene glycol with ascorbic acid for bowel preparation before outpatient colonoscopy: a study protocol for the multicentre, randomised, controlled E-PLUS trial

Kinichi Hotta,Yosuke Otake,Daisuke Yamaguchi,Yuichi Shimodate,Norihiro Hanabata,Hiroaki Ikematsu,Yohei Yabuuchi,Yasushi Sano,Ryo Shimoda,Shinya Sugimoto,Mari Oba,Hiroyuki Takamaru,Kouichiro Kimura,Yoshihiro Kishida,Kazunori Takada,Sayo Ito,Kenichiro Imai,Kazuya Hosotani,Tatsuro Murano,Masayoshi Yamada,Kensuke Shinmura,Rio Takezawa,Michito Tomonaga,Yutaka Saito
DOI: https://doi.org/10.1186/s12876-024-03146-6
2024-02-05
BMC Gastroenterology
Abstract:Sodium picosulfate (SP)/magnesium citrate (MC) and polyethylene glycol (PEG) plus ascorbic acid are recommended by Western guidelines as laxative solutions for bowel preparation. Clinically, SP/MC has a slower post-dose defaecation response than PEG and is perceived as less cleansing; therefore, it is not currently used for major bowel cancer screening preparation. The standard formulation for bowel preparation is PEG; however, a large dose is required, and it has a distinctive flavour that is considered unpleasant. SP/MC requires a small dose and ensures fluid intake because it is administered in another beverage. Therefore, clinical trials have shown that SP/MC is superior to PEG in terms of acceptability. We aim to compare the novel bowel cleansing method (test group) comprising SP/MC with elobixibat hydrate and the standard bowel cleansing method comprising PEG plus ascorbic acid (standard group) for patients preparing for outpatient colonoscopy.
gastroenterology & hepatology
What problem does this paper attempt to address?